Trump administration appoints new FDA leaders amid ongoing controversies

In early 2021, the Trump administration appointed four officials to senior roles at the FDA, including Dr. Michael Davis as head of the Center for Drug Evaluation and Research and Karim Mikhail as director of the vaccines center. These appointments aimed to stabilize the agency after a series of controversies and high-profile departures. The new leaders will address ongoing scrutiny regarding drug approvals and vaccine policies, particularly in light of recent developments in psychedelic drug research and COVID-19 vaccine regulations.